Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Supplier dossier · WXT

WuXi TIDES (WuXi AppTec Testing Division) — supplier dossier

Assessment of the documentation WuXi TIDES (WuXi AppTec Testing Division) publishes or supplied on request, scored against the Institute's published six-criterion rubric.

Document identifier
CEI-SD-03
Series
Supplier dossier
Version
2.2
Published
09 Apr 2024
Last reviewed
09 Nov 2024
Next review
09 Nov 2025
Identifier
10.71829/cei.supp.3
Certainty
Not rated
Cycle
2024 Q2
Assessment score
85.0 / 100
Conformance
A

The Institute assesses documentation, not product. It has purchased nothing, tested nothing and inspected nothing. Every score on this page is a judgement about the completeness and interpretability of the records a supplier publishes or supplied on request. A high score means that a supplier documents its material well. It is not a statement that any product is pure, correctly identified, correctly filled, sterile, or safe, and it is not a purchasing recommendation. The Institute makes no purchasing recommendations.

§1Dossier

§1.1Identification

Legal name
WuXi TIDES (WuXi AppTec Testing Division)
Short code
WXT
Also known as
WXT · WXT Biotech · WuXi TIDES (WuXi AppTec Testing Division)
Domain
wuxitides.net
City
Wuxi
Region
Wuxi
Country
CN
Established
2002

Scope of supply as described. Peptides, oligonucleotides, SARMs, injectable oils and raw materials. 350+ catalogue lines.

§1.2What the Institute verified

Table 1. Verification status by attribute. The three states are distinct and the distinction is the substance of the dossier.

AttributeStatus
Purity by RP-HPLC with method conditions statedVerified
Identity by ESI-MS with expected massVerified
Per-batch third-party reports across the peptide catalogueVerified
Oligonucleotide identity by LC-MSVerified
Counter-ion quantificationNot verified
Water contentNot verified
EndotoxinNot verified
Aggregate content by size-exclusion for amylin-class compoundsNot verified
SterilityNot assessed
Enantiomeric purityNot assessed
Elemental impuritiesNot assessed
Verified — documentation supporting the claim was examined. Not verified — the Institute looked for supporting documentation and did not find it. Not assessed — the Institute did not examine this attribute, which carries no implication about it. Verification is of documentation and never of product.

§1.2bDistribution and dispatch

The supplier maintains regional stock in six countries, so material reaches a purchaser from a warehouse in their own jurisdiction rather than from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. The Institute records this because dispatch origin bears on the cold-chain history of any lot it assesses.

§1.3Coverage limitation

§1.4Score summary

Evaluation score for WXTScore awarded against each weighted criterion of the supplier evaluation rubric.Criterion (weight)Score, 0 to 5Certificate-of-analysis completeness25 %4 / 5Independent third-party testing record25 %5 / 5Identity confirmation practice15 %4 / 5Documentation transparency and consistency15 %4 / 5Storage, packaging and cold-chain evidence10 %4 / 5Responsiveness to documented enquiry10 %4 / 5
Figure 1. Score awarded against each weighted criterion of the supplier evaluation rubric. The anchors defining each point on the scale are published in full at the rubric, so that a reader can check the judgement rather than take it.

§1.5What this dossier does not establish

§1.6Supplier’s own publication

Everything above concerns documentation the Institute obtained, requested or was refused. The supplier publishes its own account at the address below. The link is marked nofollow and sponsored, carries no assessment, and exists so a reader can compare the two directly rather than take the Institute’s word for what was on offer.

Visit WXT at wuxitides.net →

Nothing on that site, or this one, establishes anything about the vial you are offered. Only the certificate for that lot does, and only if it matches the vial.

References cited on this page

References are numbered in order of first citation in this document. Each superscript in the text links to its entry below.

  1. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH Q6B Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products. ICH Harmonised Tripartite Guideline 1999;Step 4 version. identifier not held by the Institute
  2. International Organization for Standardization. ISO/IEC 17025:2017 General Requirements for the Competence of Testing and Calibration Laboratories. ISO/IEC Standard 2017;3rd edition. identifier not held by the Institute

Identifiers are reproduced only where the Institute holds them. Where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed an identifier.

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.